News

A Phase 3 clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

Elevated pressure can lead to irreversible optic nerve damage, vision loss

Pfizer Inc. and BioNTech SE this week announced their mRNA-based coronavirus vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without evidence of infection.

The University of California San Francisco this week debuted the UCSF Wayne and Gladys Valley Center for Vision, bringing its vision care and research facilities under one roof.

Optics block out-of-focus and stray light, allow continuum of vision.

Device allows visually impaired to recognize shapes, distinguish between light and dark.

Research could lead to a novel therapeutic strategy for blinding disease

The program is dedicated to the education of fellows and residents and offers a unique opportunity to share notable retina research with peers and mentors.

Study examines use of fluocinolone acetonide for treating DME in patients.

Study shows improvements in signs, symptoms after 3 months of treatment

New paradigm-changing treatments for young patients on the horizon.

Check out the latest cartoon!

Interest stems from the recognition that the number of people affected with cataracts is expected to increase in association with population aging while access to cataract surgery is limited in areas throughout the world.

Investigators suggest incorporating an examination for mites as part of the preoperative evaluation.

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.

Investigators research safety, efficacy of endolaserless vitrectomy.

The year 2020 dished up a November surprise with a tie between Bascom Palmer Eye Institute and the Wilmer Eye Institute at the top of the rankings for Best Overall Program in the Ophthalmology Times® Best Program Survey.

Using active learning approach can help gauge visual function loss in patients

Congress paused Medicare sequester cuts to offer relief amid the pandemic. Now, the leaders of the American Medical Association, American Hospital Association, American Health Care Association, and National Association for Home Care & Hospice are urging congressional leadership to keep the pause in place.

The FDA has approved loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of the signs and symptoms of dry eye disease.

Researchers evaluate effects of procedure on patients with abnormal topography

Watchful waiting may prove to be beneficial in complicated cases

Dilation may be an important step to reduce the rate of ungradable images

This ability would unlock possibilities for repairing tissue damaged by disease

Masks that become damp should be replaced, but health officials say that not enough people know this.

Investigators have found that the diameter of retinal veins may be linked directly to the severity of COVID-19. Assessing the retinal veins may be a part of diagnosing and managing the disease.

Intravitreal gene therapy continues to be well tolerated and shows robust efficacy